tiprankstipranks

Kilian Kelly Insider Profile

4 Followers
Kilian Kelly, Chief Executive Officer & Managing Director at Cynata Therapeutics Limited, holds 619.65K shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought $94,143 shares of Cynata Therapeutics Limited on Nov 22, 2023 for an estimated value of 12.44K.
tipranks
Kilian  Kelly

Kilian Kelly
Cynata Therapeutics Limited (CYYNF)
Chief Executive Officer & Managing Director

Not Ranked
Kilian Kelly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$118K
100.00%
A breakdown of Kilian Kelly's holdings

Insider Roles

Cynata Therapeutics Limited
(CYYNF)
Chief Executive Officer & Managing Director
Roles that Kilian Kelly holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kilian Kelly

Kilian Kelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cynata Therapeutics Limited
Nov 22, 2023
Chief Executive Officer & Managing Director
Informative Buy
12.44K
$117.73K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 22, 2023
Informative Buy
AU$12.44K
-
AU$0.13
List of latest transactions for each holding click on a transaction to see Kilian Kelly's performance on stock

Kilian Kelly insider profile FAQ

What is the percentage of profitable transactions made by Kilian Kelly?
The percentage of profitable transactions made by Kilian Kelly is ―.
    What is the average return per transaction made by Kilian Kelly?
    The average return per transaction made by Kilian Kelly is ―.
      What stocks does Kilian Kelly hold?
      Kilian Kelly holds: CYYNF stocks.
        What was Kilian Kelly’s latest transaction?
        Kilian Kelly latest transaction was an Informative Buy of $12.44K.
          What was Kilian Kelly's most profitable transaction?
          Kilian Kelly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kilian Kelly's role in Cynata Therapeutics Limited?
            Kilian Kelly's role in Cynata Therapeutics Limited is Chief Executive Officer & Managing Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.